Clinical Trial Update: Omega 3 in Intervention Spinal Cord Injured People [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluated omega-3 fatty acids in people with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Lipid Metabolism Disorders, Peroxidase; Defect | Phase 2, Phase 3 | Status: COMPLETED